title: [Parkinsonism induced by sulpiride and veralipride: two different stories].
authors.forename: José Félix
authors.initials: JF
authors.lastname: Martí Massó
authors.forename: Javier
authors.initials: J
authors.lastname: Ruiz-Martínez
authors.forename: Alberto
authors.initials: A
authors.lastname: Bergareche
authors.forename: Adolfo
authors.initials: A
authors.lastname: López de Munain
mesh_terms: D000328:Adult; D000368:Aged; D001925:Brain Damage, Chronic / Q000139:chemically induced; D000075202:Contraindications; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D005060:Europe; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015394:Molecular Structure; D009422:Nervous System Diseases / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy / Q000503:physiopathology; D020734:Parkinsonian Disorders / Q000139:chemically induced*; D012189:Retrospective Studies; D056737:Safety-Based Drug Withdrawals; D013030:Spain; D013329:Structure-Activity Relationship; D013469:Sulpiride / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014103:Torticollis / Q000139:chemically induced
chemical_list: D013469:Sulpiride; C027429:veralipride